Ropharma Sa (0NZQ) Cotización

NEWS: Annual Letter to Shareholders, 2024 In Review
TEKUMO, Inc
Tue, January 7, 2025 at 8:30 AM EST 8 min read


In This Article:
TKMO
+50.00%
TEKUMO, Inc
TEKUMO, Inc
New York, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Tekumo Inc. (TKMO o

$PSRU Overview https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175607135

Expecting the first main updates in 2025 to be on:

- Start of 6-week marketing blitz in Africa for the streaming of Providence Film Group owned movies to up to 1+ Billion users in Af

Hey folks, the lawsuit website will be live in a few days, the developers have the evidence repository working and the security platform is also set (preventing any malware or cyber-attacks coming in through the evidence upload procedure). The Dev-Site was finished, but the content managers left

Hey folks, the lawsuit website will be live in a few days, the developers have the evidence repository working and the security platform is also set (preventing any malware or cyber-attacks coming in through the evidence upload procedure). The Dev-Site was finished, but the content managers left

As Sab has pointed out, volume is key. So far it is decreasing as the stock rises.
There is a gap @ 8.65. https://invst.ly/18bamo

CHPT....PLUG......FREY......................https://stockcharts.com/h-sc/ui?s=FREY&p=D&yr=0&mn=2&dy=12&id=p84071410134

$IMRX reported Phase 2a data for IMM-1-104 in pancreatic cancer, showing 43% ORR and 86% DCR in 1st-line Gemcitabine/nab-paclitaxel combo, with tumor shrinkage in all patients on FOLFIRINOX combo, and 52% disease control in 2nd-line monotherapy. Favorable safety profile supports its potential as a b

Exactly especially with all the bold and red.

LOL

https://seekingalpha.com/pr/19961230-ctt-pharma-and-johns-hopkins-university-submits-proposal-for-15-million-nih-grant-for-smoking

Maybe you didn't hear----GlobeTopper Achieves Record $4.3M in December 2024 Revenue

Adnexus has solidified its commitment to innovation through a strategic partnership with 1606 Corp (OTC PINK:CBDW), aiming to expand its AI-driven healthcare solutions. This collaboration underscores Adnexus's dedication to advancing global health outcomes.

Guess who is angry with the New York Times?

By Silvio Canto, Jr.

South of the border, the New York Times "esta haciendo olas" as they say in Spanish when someone is making waves. Yes, it's turned into a big back and forth over fentanyl plants. Here is the story:

GM LD!!

"Is Rigetti Computing Stock a Buy in 2025?"

https://www.msn.com/en-us/money/savingandinvesting/is-rigetti-computing-stock-a-buy-in-2025/ar-AA1x6An1?ocid=msedgntp&pc=U531&cvid=6e8d695da5a94242af690b2cbd2621de&ei=12

I've heard the tune a time or two. Exciting times ahead. They're working with so many of the big league companies, it has to rub off on the share price one day.

Lmfao, thanks so much for the concerns. Maybe reach out to new management with those concerns, actual shareholders have. Let us know what you hear. I’ll wait… crickets..

Lmfao.

Innoviz, in Collaboration with NVIDIA, Showcasing Cutting-Edge Perception Software with NVIDIA DRIVE AGX Orin at CES 2025, Unveiling New Software-Driven Features
January 07 2025
https://ih.advfn.com/stock-market/NASDAQ/innoviz-technologies-INVZ/stock-news/95207676/innoviz-in-collabora

Silvercorp Reports on El Domo Project DevelopmeSint Progress and Awarding the First Construction Contract
January 07 2025 - 8:00AM
PR Newswire (US)

Silvercorp Metals Inc. (CNW Group/Silvercorp Metals Inc)

Trading Symbols: SVM (TSX/NYSE Amer

Joined you there too.


SVMH

Good morning everyone ! :) 

I personally know several people who have died due to rGBM.

Sure. Even if you believed the ridiculous new underpowered rGBM arm that apparently conveniently isn't affected by the primary investigators lack of understanding of PSPD in this trainwreck of a trial, those several people y

Top 15 at 8:15
https://ih.advfn.com/markets/nasdaq/premarket
Lot to choose from

The baseline differences will have already been adjusted for in the results with the co-variate 'baseline scores' ajustment to help balance any impacts of baseline start differences.

Donnanemab also had a slight baseline ADAS COG imbalance which also would have been adjusted for in th

There is zero substance here to move the needle. Just nothing. Got to give credit to the chinamen for pulling off this scam with their eyes half closed😆 Let's see If they have one more pump before this hits the bottom of the otc cesspool.